APRICUS BIOSCIENCES, INC. (34) | Intellectual Property (2)
- Amendment to License Agreement, dated as of February 8, 2019, by and among Ligand Pharmaceuticals Incorporated, Neurogen Corporation, CyDex Pharmaceuticals, Inc., and Seelos... (Filed With SEC on March 17, 2020)
- Amended and Restated Exclusive License Agreement, dated August 29, 2019, by and between Seelos Therapeutics, Inc. and Stuart Weg, MD (Filed With SEC on November 7, 2019)
